Dare Bioscience (DARE) Other financing activities (2014 - 2023)
Dare Bioscience's (DARE) quarterly Other financing activities came in at $4.7 million in Q4 2023, up 3891.1% YoY from $118360.9 in Q4 2022, and up 3891.1% on a QoQ basis from -$124605.0 in Q4 2022.
Dare Bioscience (DARE) Other financing activities (2014 - 2023) Analysis & Trends
Dare Bioscience (DARE) has 4 years of Other financing activities data on file, last reported at $4.7 million in Q4 2023.
- Quarterly Other financing activities rose 3891.1% year-over-year to $4.7 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $4.6 million (down 92.21% YoY) and the FY2025 annual result came in at $321686.0, up 305.62% from the prior year.
- Other financing activities advanced to $4.7 million in Q4 2023, from -$124605.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $4.7 million in Q4 2023 to a low of -$124605.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4.72 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Dec 31, 2022 | -124,605.00 |
| Dec 31, 2022 | -124,605.00 |
| Mar 31, 2015 | 19,000.00 |
| Mar 31, 2015 | 19,000.00 |
| Dec 31, 2014 | 1,000.00 |
| Dec 31, 2014 | 1,000.00 |
| Sep 30, 2014 | 59.44 Mn |
| Sep 30, 2014 | 59.44 Mn |
| Jun 30, 2014 | -641,000.00 |
| Jun 30, 2014 | -641,000.00 |
| Mar 31, 2014 | 1.07 Mn |
| Mar 31, 2014 | 1.07 Mn |